Peixin Technology develops AI-assisted medical imaging analysis and surgical planning products.
Peixin Technology develops AI-assisted medical imaging products for image mapping, fusion, diagnosis, and surgical planning using CT, ultrasound, and MRI data. Its CardioVerse system assesses heart valves and supports surgical risk assessment and planning. Founded in 2021, the company is based in Suzhou, China. In August 2023, it raised pre-Series A funding led by Lilly Asia Ventures, with Suzhou Jiasheng Venture Capital Management and Leader Venture Capital participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in